| Bruce A Jacobson M D A Professional Corporation | |
|
7301 Medical Center Drive Suite 404 West Hills CA 91307 | |
| (818) 347-3239 | |
| (818) 348-0444 |
| Full Name | Bruce A Jacobson M D A Professional Corporation |
|---|---|
| Speciality | Internal Medicine |
| Location | 7301 Medical Center Drive, West Hills, California |
| Authorized Official Name and Position | Bruce A Jacobson (OWNER) |
| Authorized Official Contact | 8183473239 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Bruce A Jacobson M D A Professional Corporation 7301 Medical Center Drive Suite 404 West Hills CA 91307 Ph: (818) 347-3239 | Bruce A Jacobson M D A Professional Corporation 7301 Medical Center Drive Suite 404 West Hills CA 91307 Ph: (818) 347-3239 |
| NPI Number | 1548338429 |
|---|---|
| Provider Enumeration Date | 12/01/2006 |
| Last Update Date | 08/31/2020 |
| Medicare PECOS PAC ID | 4486975752 |
|---|---|
| Medicare Enrollment ID | O20150706001745 |
News Archive
Scientists have used a glowing protein from fireflies to observe the activity of a molecule that is an important target for new drugs to treat cancer, autoimmune diseases and several other disorders.
In this Huffington Post "Black Voices" opinion piece, Vanessa Cullins, vice president for external medical affairs at Planned Parenthood Federation of America, responds to an announcement by the WHO in February that the agency would not revise its contraception guidelines for women living with and at risk of HIV infection based on a "study suggesting that hormonal contraception increases women's risk of acquiring and transmitting HIV to their partners."
MRI Medical Inc. is changing its name to Xeridiem Medical Devices, Inc. as part of its corporate development plan.
Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review classification to its Supplemental New Drug Application (sNDA) regarding ISTODAX (romidepsin) for injection for the treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy.
Many scientists have explored the use of new as well as already approved drugs for this condition, and one of the very few promising leads is dexamethasone. Dexamethasone is a corticosteroid, which has been reported in some earlier studies to reduce mortality in these patients by 18% and 36% in COVID-19 patients who are on oxygen and ventilators, respectively.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548338429 | NPI | - | NPPES |
| 00A29702 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | A43500 (California) | Secondary |
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Bruce A Jacobson |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1558314971 PECOS PAC ID: 8527061787 Enrollment ID: I20060809000265 |
News Archive
Scientists have used a glowing protein from fireflies to observe the activity of a molecule that is an important target for new drugs to treat cancer, autoimmune diseases and several other disorders.
In this Huffington Post "Black Voices" opinion piece, Vanessa Cullins, vice president for external medical affairs at Planned Parenthood Federation of America, responds to an announcement by the WHO in February that the agency would not revise its contraception guidelines for women living with and at risk of HIV infection based on a "study suggesting that hormonal contraception increases women's risk of acquiring and transmitting HIV to their partners."
MRI Medical Inc. is changing its name to Xeridiem Medical Devices, Inc. as part of its corporate development plan.
Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review classification to its Supplemental New Drug Application (sNDA) regarding ISTODAX (romidepsin) for injection for the treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy.
Many scientists have explored the use of new as well as already approved drugs for this condition, and one of the very few promising leads is dexamethasone. Dexamethasone is a corticosteroid, which has been reported in some earlier studies to reduce mortality in these patients by 18% and 36% in COVID-19 patients who are on oxygen and ventilators, respectively.
› Verified 9 days ago
News Archive
Scientists have used a glowing protein from fireflies to observe the activity of a molecule that is an important target for new drugs to treat cancer, autoimmune diseases and several other disorders.
In this Huffington Post "Black Voices" opinion piece, Vanessa Cullins, vice president for external medical affairs at Planned Parenthood Federation of America, responds to an announcement by the WHO in February that the agency would not revise its contraception guidelines for women living with and at risk of HIV infection based on a "study suggesting that hormonal contraception increases women's risk of acquiring and transmitting HIV to their partners."
MRI Medical Inc. is changing its name to Xeridiem Medical Devices, Inc. as part of its corporate development plan.
Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review classification to its Supplemental New Drug Application (sNDA) regarding ISTODAX (romidepsin) for injection for the treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy.
Many scientists have explored the use of new as well as already approved drugs for this condition, and one of the very few promising leads is dexamethasone. Dexamethasone is a corticosteroid, which has been reported in some earlier studies to reduce mortality in these patients by 18% and 36% in COVID-19 patients who are on oxygen and ventilators, respectively.
› Verified 9 days ago
Gary H Nudell M D A Professional Corporation Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 7345 Medical Center Dr Ste 160, West Hills, CA 91307 Phone: 818-676-4806 Fax: 818-676-4820 | |
Vahid Hemat Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 23101 Sherman Pl, Suite 407, West Hills, CA 91307 Phone: 818-999-3800 Fax: 818-999-3808 | |
Insite Digestive Health Care - West Hills Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7320 Woodlake Ave Ste 310, West Hills, CA 91307 Phone: 818-346-9911 | |
Tigalat Shalita D O Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 7230 Medical Center Dr Ste 202, West Hills, CA 91307 Phone: 818-676-0080 Fax: 818-676-0090 | |
Canoga Park Medical Group A Professional Corp Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7301 Medical Center Dr, Suite 405, West Hills, CA 91307 Phone: 818-347-3077 Fax: 818-347-8334 | |
Marc I. Lavin M.d., A Professional Medical Corporation Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 7345 Medical Center Dr Ste 160, West Hills, CA 91307 Phone: 818-676-4805 Fax: 818-676-4820 | |
Medhi Izadi, Do Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7301 Medical Center Dr Ste 302, West Hills, CA 91307 Phone: 818-888-3387 |